Walnuts are rich in polyphenols ellagitannins, modulate gut microbiota (GM), and exert health benefits after long-term consumption. The metabolism of ellagitannins to urolithins via GM depends on urolithin metabotypes (UM-A, -B, or -0), which have been reported to predict host responsiveness to a polyphenol-rich intervention. This study aims to assess whether UMs were associated with differential GM modulation after short-term walnut consumption. In this study, 27 healthy individuals consumed 33 g of peeled raw walnuts over three days. GM profiling was determined using 16S rRNA illumina sequencing and specific real-time quantitative polymerase chain reactions (qPCRs), as well as microbial activity using short-chain fatty acids analysis in stool samples. UMs stratification of volunteers was assessed using ultra performance liquid chromatography-electro spray ionization-quadrupole time of flight-mass spectrometry (UPLC-ESI-QTOF-MS) analysis of urolithins in urine samples. The gut microbiota associated with UM-B was more sensitive to the walnut intervention. Blautia, Bifidobacterium, and members of the Coriobacteriaceae family, including Gordonibacter, increased exclusively in UM-B subjects, while some members of the Lachnospiraceae family decreased in UM-A individuals. Coprococcus and Collinsella increased in both UMs and higher acetate and propionate production resulted after walnuts intake. Our results show that walnuts consumption after only three days modulates GM in a urolithin metabotype-depending manner and increases the production of short-chain fatty acids (SCFA).
Introduction
Nuts are a significant source of macronutrients (e.g., proteins, unsaturated fats, polysaccharides, fiber), micronutrients (e.g., vitamins and minerals), and bioactive compounds (e.g., tocopherols, phytosterols, phenolic compounds [1] ). Ellagitannins (ETs) and ellagic acid (EA) are polyphenols present in nuts, pomegranates, and berries [2] . The human gut microbiota can metabolize ETs and EA into the bioactive metabolites urolithins by lactone-ring cleavage, decarboxylation, and dehydroxylation reactions [3] . Epidemiologic studies have associated long-term nut consumption with a reduced incidence of coronary heart disease, hypertension, and cholesterol-lowering effect [4] . The health-related effects of nut consumption may be linked to gut microbiota, which can release bioactive compounds with higher bioavailability and functionality than parental compounds [5] . Several studies have demonstrated changes in gut microbial communities after the intake of ETs-containing foods on week timescale [2, [6] [7] [8] [9] [10] . Besides, some of these studies revealed a personalized effect of foods containing ETs [6] , which supports the concept of personalized nutrition. According to how ETs metabolize via gut microbiota, individuals can be stratified into three urolithin metabotypes (UMs) [11, 12] . Metabotype A (UM-A) is characterized by the production of urolithin-A (Uro-A). Metabotype B (UM-B) is characterized by the production of urolithin-B (Uro-B), isourolithin-A (IsoUro-A), and Uro-A. Metabotype 0 (UM-0) does not produce these final urolithins [11] . Recently, three urolithin-producing bacteria belonging to the genus Gordonibacter (G. pamelaeae and G. urolithinfaciens) and Ellagibacter isourolithinifaciens were isolated from human feces [13] [14] [15] [16] . UMs have been proposed as potential cardiovascular disease (CVD) risk biomarkers [17] . Furthermore, UMs were associated with the host blood lipid profile and with the interindividual variability in the improvement of cardiovascular risk biomarkers after the consumption of pomegranate ellagitannins for six weeks [6, 17] . In this scenario, this study aims to evaluate the impact of a short-term (three days) nutritional intervention with walnuts on the gut microbiota composition and function in healthy individuals according to their UMs.
Materials and Methods

Study Design and Participants
A total of 27 healthy individuals (Valencia, Spain) were enrolled in the study. The inclusion criteria were for participants to be older than 18 years old, have a non-declared pathology, and not have taken antibiotics, medication, or pre/probiotics in the two months before the study. The intervention consisted of an intake of 33 g of walnuts per day for three days. A total of 100 g of peeled walnuts provided with 65 g of fats (SFA: 6.4 g; MUFA: 10 g; PUFA: 48 g), 4 g of carbohydrates, 15 g of protein, 12 g of dietary fiber, and 0.02 g of salt. Proanthocyanidins were quantified after acid-catalysis in the presence of phloroglucinol, as previously reported [18] . The analysis of hydrolysable tannins was performed after an acid hydrolysis of nut samples using a method previously reported [19] .
Walnut samples contained (mg/g fresh weight; mean ± SD): ellagic acid 4.15 ± 0.60; gallic acid 0.48 ± 0.07; and catechin 0.44 ± 0.04. At the beginning (T0) and the end (T3) of these time-points, participants collected fecal samples for gut microbiota analysis and short fatty acids (SCFA) determination and urine for urolithin determination and subsequent UMs stratification. Moreover, each participant filled out a questionnaire about their clinical, anthropometric, and nutritional records at the end of the interventional study. Additionally, the intake of ellagitannins-containing food, as pomegranate and berries were restricted throughout the intervention study. BMI was calculated and stratified as following: lean-normal weight (≤25.0 kg/m 2 ), overweight (25.0-30.0 kg/m 2 ), and obese (≥30.0 kg/m 2 ) [20] . Written informed consent was obtained from all the volunteers. The local ethics committee of Atención Primaria-Generalitat Valenciana (CEIC-APCV) approved the study protocol. All experiments were carried out following approved guidelines and regulations. 
Baseline Microbiota Composition is Urolithin-Metabotype Dependent
Baseline microbiota (T0, n = 27) was characterized by the presence of Firmicutes with a mean relative abundance and SD of 77.31% ± 2.88, followed by Bacteroidetes (15.86% ± 0.28), Actinobacteria (3.13% ± 0.65), Verrucomicrobia (1.78% ± 1.22), and Proteobacteria (1.31% ± 1.50) at the phylum level. The relative abundance of phylum Synergistetes was significantly enriched in UM-B (p < 0.05) compared to UM-A. At the family level, the family Lachnospiraceae was associated with UM-A, whereas the abundance of the families Cerasicoccaceae, Peptostreptococcaceae, Synergistaceae, and Paraprevottelaceae were related to UM-B. A redundancy analysis (RDA) on genus level showed significant differences in the microbial population, according to UMs (p = 0.025) ( Figure 1A ). Volunteers belonging to UM-B had a higher richness (p = 0.003, Chao 1 index) than UM-A ( Figure 1B ).
Lefse analysis showed that Dorea, Holdemania genus, and members of Lachnospiraceae family were enriched in UM-A, while genus cc_115, Oxalobacter, members of Synergistaceae, Cerasicoccaceae, Coriobacteriacea, Peptostreptococcaceae family, and Paraprevotella were associated with UM-B individuals ( Figure 1C ).
Lefse analysis showed that Dorea, Holdemania genus, and members of Lachnospiraceae family were enriched in UM-A, while genus cc_115, Oxalobacter, members of Synergistaceae, Cerasicoccaceae, Coriobacteriacea, Peptostreptococcaceae family, and Paraprevotella were associated with UM-B individuals ( Figure 1C ). 
Microbiota Composition of UM-B is Sensitive to Walnuts Consumption
The redundancy analysis (RDA) of all individuals (n = 27) showed that bacterial communities were significantly affected by the three day walnut intervention (p = 0.001). However, when the volunteers were stratified according to their UMs, these shifts were only significant for UM-B (p = 0.017) ( Figure 2D ). At the phylum level, walnut intake decreased the relative abundance of Bacteroidetes and increased Actinobacteria when all individuals were considered (p < 0.05). These differences were consistent for UM-B after clustering. At the family level, walnut consumption increased the Coriobacteriaceae family in both UMs, while the Bifidobacteriaceae family increased after three days only for UM-B volunteers. Among bacterial genera, members of the Lachnospiraceae family decreased after the walnut intervention in UM-A individuals, Coprococcus and Collinsella increased in both UMs, whereas Blautia, Bifidobacterium, and unclassified Coriobacteriaceae increased only in participants belonging to UM-B (p < 0.05) ( Figure 2B ,E). According to the Chao1 index, gut microbial richness significantly decreased for UM-A (p = 0.024) and UM-B (p < 0.001) after walnut consumption ( Figure 2C ,F). 
Walnut Consumption Increased Faecal Gordonibacter Levels in UM-B
Before the intervention, UM-A tended to present higher counts of Gordonibacter. However, it was not significant compared to UM-B (p = 0.601) ( Figure 3A) . After intervening and analyzing the individuals as a single group, a significant increase of fecal Gordonibacter levels was observed (p = 0.024) ( Figure 3B ). After clustering, according to UMs, walnut consumption only increased Gordonibacter levels in UM-B individuals (p = 0.034) ( Figure 3C ,D). No significant associations with BMI, MD stratification, nutrient intake, or sex with Gordonibacter levels were found. Figure 3 . Microbiota composition before (T0) and after the intervention (T3). Gordonibacter levels measured using qPCR according to UMs before the intervention (A). Gordonibacter levels before and after the intervention for all the participants (B). Gordonibacter levels before and after the intervention for UM-A (C) and UM-B participants (D). Paired t-test was used to test significance differences in Gordonibacter levels before and after the intervention. Results are presented as mean ± SEM. 
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Effect of Walnut Consumption on Gut Microbiota Activity
Before the intervention, volunteers belonging to UM-A tended to present higher levels of butyrate (p = 0.070). After the intervention, we did not find significant differences in SCFA production after walnut consumption according to UMs (data not shown), but analyzing all participants as a single group, the walnut intake increased the total SCFA (p = 0.012) levels, specifically acetate (p= 0.021) and propionate (p = 0.040) (Figure 4 ). 
Associations between Gut Microbiota Composition/Activity and Walnut Intervention
Before the walnut intervention, at the genus level a positive correlation was found between the increase in acetate and Phascolarctobacterium (p = 0.006) and Anaerostipes (p = 0.011), propionate and Phascolarctobacterium (p = 0.040), Coprococcus (p = 0.031) and Anaerostipes (p = 0.011), and butyrate and Coprococus (p = 0.030) and Anaerostipes (p = 0.020), respectively. At the species level, we found that this positive correlation between propionate and butyrate with Coprococus was due to Coprococcus catus. After the walnut intervention, positive correlations were observed between acetate levels and Phascolarctobacterium (p = 0.018) and Dehalobacterium (p = 0.014), propionate levels and Eubacterium (p = 0.024), Phascolarctobacterium (p = 0.040), Slackia (p = 0.024), and butyrate levels with Dehalobacterium (p = 0.016), and Eubacterium (p = 0.006).
Discussion and Conclusion
Understanding individuals' response to dietary bioactive compounds such as polyphenols is essential in the context of personalized nutrition [30] . The occurrence of specific gut microbiota metabotypes can affect the metabolism and bioactivity of polyphenols and the response of individuals upon polyphenol consumption can vary [6] . Our present study shows that the impact exerted by the three day walnut intervention on the gut microbiota depends on the urolithin metabotypes (UMs) of healthy individuals. Therefore, our results add significance to previous studies that aimed to explain the controversial benefits of bioactive compounds present in foods due to the inherent high inter-individual variability [6] . Notably, only UM-B participants responded significantly to the intervention with walnuts towards a change in the gut microbiota composition. 
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Parameters such as baseline gut microbiota composition and habitual daily intakes may influence a differential host response [31] . Furthermore, gut microbiota composition would be considered as a predictor for the inter-individual variability in response to dietary interventions [31] . Although UM groups did not present differences in their dietary intakes, significant differences in the gut microbial composition, according to UMs clustering, were observed. In agreement with another study [32] , higher relative abundances of Synergistetes phylum and members of Coriobacteriaceae family were observed in UM-B individuals, whereas members of the Lachnospiraceae family predominated in UM-A. We also found a higher gut microbiota richness in UM-B individuals in agreement with Romo-Vaquero and colleagues [32] . Differences of basal microbiota in UMs may be linked to the individual response to ETs intake. It has been reported that intervention with an ellagitannin-rich pomegranate extract for three weeks exerted a differential impact on cardiovascular risk markers of individuals depending on their UM metabotype [6] . The cardiovascular benefits were mainly observed in UM-B individuals, who initially presented a higher cardiovascular risk [6] . These results are in agreement with our present study, where only UM-B subjects responded significantly to the walnut intervention. Moreover, a previous study that evaluated the capacity to produce nut phenolic metabolites in subjects with metabolic syndrome showed that several urolithins significantly increased after a nut-enriched-diet. However, this pathology is associated with an altered gut bacterial diversity [33] .
Overall, the evidence on the impact of walnuts on the gut microbiota is scarce and mainly provided by long-term interventions where the significance of the gut microbiota metabotypes, linked to the inter-individual variability, was not explored [8, 9, 34] . In agreement with González-Sarrías et al., our results supported the personalized effect associated with ellagitannin-containing foods consumption [6] . In the present study, a three day walnut intervention modulated some microbial groups, including the increase of Blautia, Bifidobacterium and bacterial members of Coriobacteriaceae, such as Gordonibacter, but only in UM-B individuals. Previous research has shown that walnut consumption increased the relative abundance of butyrate-producing species, although the authors observed opposite results on some bacterial groups such as Ruminococcus and Bifidobacteria [8, 35] . Holscher et al. assessed the impact of consuming 42 g walnuts per day for two three week periods on the human gut microbiota composition and observed a decrease in the relative abundance of Ruminococcus and Bifidobacteria [8] . However, another recent study showed that the same amount of walnuts per day enhanced the abundance of Ruminococcaceae and Bifidobacteria [35] . The effect of walnut consumption on the gut microbial composition may be linked to ellagic acid and ellagitannins, but other polyphenols and other compounds such as dietary fiber and unsaturated fats [4] would also be influencing factors.
The highest content in omega-3 fatty acids characterizes walnuts with respect to other nuts [36, 37] . Although the impact of polyunsaturated fatty acids on the gut microbiota is poorly defined, several human studies have shown some common changes in the gut microbiota after omega-3 PUFA supplementation. In particular, a decrease in Faecalibacterium, from Ruminococcaceae family, often associated with an increase in other butyrate-producing bacteria belonging to the Lachnospiraceae family has been observed [38] . Walnuts present similarities in the chemical composition with other nuts, like almonds and pistachios, which do not contain ellagitannins. Some studies have investigated the effects of other dried fruits and nuts on the gut microbiota composition [9, 34, 39] . Ukhanova et al. demonstrated enrichment in butyrate producers after almonds and pistachios consumption for 18 days [34] . Holscher and colleagues performed an interventional study with almonds and found an increase in the relative abundances of several butyrate-producing bacteria such as Lachnospira, Roseburia, and other bacterial groups such as Dialister and Oscillospira [9] . In any case, all these studies focused on changes in gut microbial composition and agreed on the same point that these interventions produced an increase in butyrate-producing bacteria. In our study, a three-day walnut intervention was enough to increase acetic acid and propionate of fecal samples, without differences between UMs. Riviére et al. reported health benefits of propionate in mice by reducing serum cholesterol, improving insulin sensitivity, and promoting satiety [40] . Recently, the use of inulin-propionate ester, to deliver propionate to the colon selectively, improved insulin resistance in overweight and obese subjects [41] . A recent study (including 365 study participants in 13 trials) found that diets enriched with walnuts led to lower total and LDL-cholesterol when compared with other diets [42] . It has also been reported that walnut consumption is associated with a lower risk of type 2 diabetes [4] . The PREDIMED trial is the largest primary prevention trial showing that an intervention to promote a Mediterranean diet, which is beneficial against the incidence of several major chronic diseases in subjects at high cardiovascular risk, particularly when improved adherence to the Mediterranean diet includes increased consumption of extra virgin olive oil and mixed tree nuts. The PREDIMED trial showed that participants included in the MD group supplemented with nuts presented a lower risk of cardiovascular events and type 2 diabetes [43, 44] .
The increase in acetate production is in accordance with the increase in the relative abundances of the Bifidobacterium genus. Moreover, acetate is used by cross-feeding species as a co-substrate to produce butyrate [40] . Therefore, this could mean that the increase of Bifidobacterium could favor the colonization of other beneficial butyrate-producing bacteria, such as Coprococcus, leading to an increase in butyrate production. Although we did not observe a significant increase in butyrate production, which could have been due to the short-term walnut intervention, we found positive correlations between higher acetate and propionate production, and Phascolarbacterium, Coprococcus, and Anaerostipes. These results agree with previous studies that described the production of SCFA, including acetate and propionate, by Phascolarctobacterium [45] as well as the production of butyrate by Coprococus and Anaerostipes [40] . At the species level, we also observed positive correlations between Coprococcus catus, butyrate, and propionate concentrations. This is related to the capability of this bacterial species for butyrate and propionate production, via butyryl-CoA: acetate CoA-transferase route and acrylate pathway, respectively [45] . It is well known that butyrate exerts health benefits, including the preservation of the gut barrier integrity. Remarkably, it has been demonstrated that urolithin-A (Uro-A), as a microbial metabolite, significantly enhances the gut barrier function through the up-regulation of the epithelial tight junctions' proteins [46] , which confirmed pioneering investigations of our group that demonstrated for the first time the preservation of the colon architecture by Uro-A under intestinal inflammation [2] . Although fecal SCFA profiles are widely used as markers of gut health or disease, caution on interpreting the results may be required. More than 95% of SCFAs in the gut are quickly absorbed. Therefore, measurement of fecal SCFAs concentration only represents the 5% of produced SCFA left unabsorbed. Luminal concentrations of SCFAs can be affected by both rates of production and disappearance, circadian rhythms, section of the intestine, and specific microenvironment at luminal or mucosal compartments [47] .
In summary, the main findings of this interventional study show that walnut consumption for three days is enough to modulate gut microbial composition in a UM-depending manner and to increase the production of SCFA. This study supports the concept of personalized nutrition and that not all the dietary recommendations may exert the same benefits in all individuals. This concept is growing and there is enough evidence that explains that a complex relationship between diet and microbiome could be behind this. Nevertheless, there are still difficulties predicting gut microbiota and host responses to a given dietary intervention. There is still no consensus because there are many parameters that we should take into account, such as host physiology, habitual dietary patterns, and gut microbiota baseline. Therefore, more research is needed and clinical trials should take into account this inter-individual variability.
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